The use of proton therapy in relatively new indications

A model-based selection approach to identify suitable indications for proton therapy

IBCD 2016: Patient access and regulatory challenges

Taking complex genomic analysis into practice

Genomic characterisation and risk stratification of AML

Screening Patients for Efficient Clinical Trial Access (SPECTA)

IBCD 2016: Integrating assays into clinical trials

Innovative imaging techinques to visualise drug targets

Design and value of immunohistochemical assays

What is the role of surgery in melanoma treatment?

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Environmental exposure and childhood leukaemia